Combined targeting of senescent cells and senescent macrophages: A new idea for integrated treatment of lung cancer
Seminars in Cancer Biology,
Journal Year:
2024,
Volume and Issue:
106-107, P. 43 - 57
Published: Aug. 29, 2024
Language: Английский
Green synthesis, in silico modeling, and biological evaluation of N-substituted (Z)-5-arylidene imidazolidine/thiazolidine-2,4-dione/4-thione derivatives catalyzed by Bu SO3H core–shell nanostructures
Malihe Akhavan,
No information about this author
Zohreh Esam,
No information about this author
Atefeh Mirshafa
No information about this author
et al.
RSC Advances,
Journal Year:
2024,
Volume and Issue:
14(32), P. 22916 - 22938
Published: Jan. 1, 2024
The
newly
designed
magnetic
nanocatalyst
Fe
3
O
4
@CPTMS@guanidine–BuSO
H
in
a
one-pot
multicomponent
reaction
is
reported
to
obtain
N
-substituted
(
Z
)-5-arylidene
imidazolidine/thiazolidine-2,4-dione/4-thione
as
highly
selective
antiproliferation
agent.
Language: Английский
Thiazolidinedione derivatives in cancer therapy: exploring novel mechanisms, therapeutic potentials, and future horizons in oncology
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 2, 2024
Language: Английский
Therapeutic Potential and Challenges of Pioglitazone in Cancer Treatment
Applied Sciences,
Journal Year:
2025,
Volume and Issue:
15(4), P. 1925 - 1925
Published: Feb. 13, 2025
Pioglitazone
(ACTOS)
is
a
thiazolidinedione
for
peroxisome
proliferator-activated
receptor
γ
(PPAR-γ)
that
has
been
well
established
the
second
or
third
line
treatment
of
type
2
diabetes
mellitus.
Beyond
effects
on
glucose
metabolism,
pioglitazone
displays
positive
lipid
blood
pressure,
endothelial
function,
bone
density,
and
apoptosis
cancer
cells.
In
fact,
according
to
in
vitro
experiments
preclinical
studies,
PPAR-γ
ligand
currently
considered
potential
target
both
chemoprevention
therapy.
ligands
are
known
inhibit
cell
proliferation
metastasis
through
terminal
differentiation
underexpression
inflammatory
mediators.
Despite
its
anticancer
properties,
was
withdrawn
by
national
medicine
agencies
France
Germany,
due
reports
increased
incidence
bladder
cancer.
These
were
associated
with
European
populations
undergoing
higher
doses
longer
durations
treatment.
this
review,
we
discuss
pharmacokinetics,
therapeutic
potential,
limitations
regarding
clinical
use
pioglitazone,
focus
Language: Английский
Decoding proteomic cross-talk between hypobaric and normobaric hypoxia: Integrative analysis of oxidative stress, cytoskeleton remodeling, and inflammatory pathways
Poornima Sharma,
No information about this author
Swaraj Mohanty,
No information about this author
Yasmin Ahmad
No information about this author
et al.
Life Sciences,
Journal Year:
2025,
Volume and Issue:
unknown, P. 123611 - 123611
Published: April 1, 2025
Language: Английский
Understanding Ibrilatazar’s mechanism of action: Addressing concerns about autophagy in cancer Therapy
Lung Cancer,
Journal Year:
2025,
Volume and Issue:
203, P. 108538 - 108538
Published: April 19, 2025
Language: Английский
Exploring transcriptomic mechanisms underlying pulmonary adaptation to diverse environments in Indian rams
Ritika Gera,
No information about this author
Reena Arora,
No information about this author
Pooja Chhabra
No information about this author
et al.
Molecular Biology Reports,
Journal Year:
2024,
Volume and Issue:
51(1)
Published: Nov. 1, 2024
Language: Английский
Identification of significant hub genes and pathways associated with metastatic breast cancer and tolerogenic dendritic cell via bioinformatics analysis
Computers in Biology and Medicine,
Journal Year:
2024,
Volume and Issue:
184, P. 109396 - 109396
Published: Nov. 16, 2024
Language: Английский
Detection of serum SNHG22 and its correlation with prognosis of non-small cell lung cancer
Quan Cheng,
No information about this author
Guoping Chen,
No information about this author
Xiaojiao Wu
No information about this author
et al.
Journal of Cardiothoracic Surgery,
Journal Year:
2024,
Volume and Issue:
19(1)
Published: Sept. 20, 2024
Language: Английский
Investigating the anti-obesity potential of Nelumbo nucifera leaf bioactive compounds through machine learning and computational biology methods
Hongyun Huang,
No information about this author
Chengyu Liu,
No information about this author
Can Cao
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 18, 2024
Obesity,
a
growing
global
health
concern,
is
linked
to
severe
ailments
such
as
cardiovascular
diseases,
type
2
diabetes,
cancer,
and
neuropsychiatric
disorders.
Conventional
pharmacological
treatments
often
have
significant
side
effects,
highlighting
the
need
for
safer
alternatives.
Traditional
Chinese
Medicine
(TCM)
offers
potential
solutions,
with
plant
extracts
like
those
from
Language: Английский